• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CyberKnife 和 EDGE 在胰腺癌立体定向体部放疗中的剂量学和放射生物学治疗计划比较。

Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

出版信息

Sci Rep. 2021 Feb 18;11(1):4065. doi: 10.1038/s41598-021-83648-5.

DOI:10.1038/s41598-021-83648-5
PMID:33603030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893157/
Abstract

To perform a comparison of the different stereotactic body radiotherapy (SBRT) plans between the Varian EDGE and CyberKnife (CK) systems for locally advanced unresectable pancreatic cancer. Fifteen patients with pancreatic cancer were selected in this study. The median planning target volume (PTV) was 28.688 cm (5.736-49.246 cm). The SBRT plans for the EDGE and CK were generated in the Eclipse and Multiplan systems respectively with the same contouring and dose constrains for PTV and organs at risk (OARs). Dose distributions in PTV were evaluated in terms of coverage, conformity index (CI), new conformity index (nCI), homogeneity index (HI), and gradient index (GI). OARs, including spinal cord, bowel, stomach, duodenum and kidneys were statistically evaluated by different dose-volume metrics and equivalent uniform dose (EUD). The volume covered by the different isodose lines (ISDL) ranging from 10 to 100% for normal tissue were also analyzed. All SBRT plans for EDGE and CK met the dose constraints for PTV and OARs. For the PTV, the dosimetric metrics in EDGE plans were lower than that in CK, except that D and GI were slightly higher. The EDGE plans with lower CI, nCI and HI were superior to generate more conformal and homogeneous dose distribution for PTV. For the normal tissue, the CK plans were better at OARs sparing. The radiobiological indices EUD of spinal cord, duodenum, stomach, and kidneys were lower for CK plans, except that liver were higher. The volumes of normal tissue covered by medium ISDLs (with range of 20-70%) were lower for CK plans while that covered by high and low ISDLs were lower for EDGE plans. This study indicated that both EDGE and CK generated equivalent plan quality, and both systems can be considered as beneficial techniques for SBRT of pancreatic cancer. EDGE plans offered more conformal and homogeneous dose distribution for PTV, while the CK plans could minimize the exposure of OARs.

摘要

为了比较瓦里安 EDGE 和 CyberKnife(CK)系统在局部晚期不可切除胰腺癌中的不同立体定向体放射治疗(SBRT)计划。本研究选择了 15 例胰腺癌患者。中位计划靶区(PTV)为 28.688cm(5.736-49.246cm)。EDGE 和 CK 的 SBRT 计划分别在 Eclipse 和 Multiplan 系统中生成,PTV 和危及器官(OAR)的轮廓和剂量限制相同。通过覆盖度、适形指数(CI)、新适形指数(nCI)、均匀性指数(HI)和梯度指数(GI)评估 PTV 中的剂量分布。通过不同的剂量-体积指标和等效均匀剂量(EUD)对脊髓、肠道、胃、十二指肠和肾脏等 OAR 进行统计学评估。还分析了正常组织不同等剂量线(ISDL)覆盖的体积,范围从 10%到 100%。EDGE 和 CK 的所有 SBRT 计划均符合 PTV 和 OAR 的剂量限制。对于 PTV,EDGE 计划的剂量学指标低于 CK,除了 D 和 GI 略高。EDGE 计划的 CI、nCI 和 HI 较低,能够更好地生成更适形和均匀的剂量分布。对于正常组织,CK 计划在保护 OAR 方面更好。除了肝脏较高外,CK 计划的脊髓、十二指肠、胃和肾脏的放射生物学指数 EUD 较低。CK 计划的中 ISDL (20-70%)覆盖的正常组织体积较低,而 EDGE 计划的高 ISDL 和低 ISDL 覆盖的正常组织体积较低。这项研究表明,EDGE 和 CK 都能产生等效的计划质量,这两种系统都可以被认为是胰腺癌 SBRT 的有益技术。EDGE 计划为 PTV 提供了更适形和均匀的剂量分布,而 CK 计划可以最大限度地减少 OAR 的暴露。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/27449c0a8312/41598_2021_83648_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/60a4e74c1012/41598_2021_83648_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/d0f9da83b639/41598_2021_83648_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/10e08df074a4/41598_2021_83648_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/6557e4389c6a/41598_2021_83648_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/05c4cb217894/41598_2021_83648_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/27449c0a8312/41598_2021_83648_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/60a4e74c1012/41598_2021_83648_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/d0f9da83b639/41598_2021_83648_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/10e08df074a4/41598_2021_83648_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/6557e4389c6a/41598_2021_83648_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/05c4cb217894/41598_2021_83648_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6da/7893157/27449c0a8312/41598_2021_83648_Fig6_HTML.jpg

相似文献

1
Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.CyberKnife 和 EDGE 在胰腺癌立体定向体部放疗中的剂量学和放射生物学治疗计划比较。
Sci Rep. 2021 Feb 18;11(1):4065. doi: 10.1038/s41598-021-83648-5.
2
Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits.射波刀立体定向体部放射治疗对局部晚期宫颈癌的剂量分析及潜在临床获益
Cancers (Basel). 2022 Oct 21;14(20):5166. doi: 10.3390/cancers14205166.
3
Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.评估 HDR 近距离治疗复制的前列腺放射治疗计划,包括适形调强放疗、Cyberknife 和 VMAT。
Med Dosim. 2022;47(1):61-69. doi: 10.1016/j.meddos.2021.08.003. Epub 2021 Sep 20.
4
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.评估蒙特卡罗算法在接受立体定向体部放射治疗的周围型肺癌患者中符合 RTOG 0915 剂量学标准的应用。
J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077.
5
Dosimetric comparison of ZAP-X, Gamma Knife, and CyberKnife stereotactic radiosurgery for single brain metastasis.ZAP-X、伽玛刀和 CyberKnife 立体定向放射外科治疗单个脑转移瘤的剂量学比较。
BMC Cancer. 2024 Aug 1;24(1):936. doi: 10.1186/s12885-024-12710-y.
6
Dosimetric and planning efficiency comparison for lung SBRT: CyberKnife vs VMAT vs knowledge-based VMAT.肺部立体定向体部放疗的剂量学与计划效率比较:射波刀与容积调强放疗对比基于知识的容积调强放疗
Med Dosim. 2020;45(4):346-351. doi: 10.1016/j.meddos.2020.04.004. Epub 2020 Jun 10.
7
Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.大体积或复杂脑肿瘤的伽玛刀立体定向放射外科治疗与基于线性加速器的治疗的剂量学特征比较。
J Neurosurg. 2016 Dec;125(Suppl 1):97-103. doi: 10.3171/2016.7.GKS16881.
8
The feasibility and efficacy of new SBRT technique HyperArc for recurrent nasopharyngeal carcinoma: noncoplanar cone-based robotic system vs. noncoplanar high-definition MLC based Linac system.基于非共面锥形机器人系统和非共面高清 MLС 直线加速器系统的新型 SBRT 技术 HyperArc 治疗复发性鼻咽癌的可行性和疗效。
Med Dosim. 2021;46(2):164-170. doi: 10.1016/j.meddos.2020.10.007. Epub 2020 Nov 15.
9
Comparison of four techniques for spine stereotactic body radiotherapy: Dosimetric and efficiency analysis.四种脊柱立体定向体部放疗技术的比较:剂量学和效率分析。
J Appl Clin Med Phys. 2018 Mar;19(2):160-167. doi: 10.1002/acm2.12271. Epub 2018 Feb 7.
10
Dosimetric comparison of helical tomotherapy and dynamic conformal arc therapy in stereotactic radiosurgery for vestibular schwannomas.螺旋断层放射治疗与动态适形弧治疗在前庭神经鞘瘤立体定向放射外科中的剂量学比较。
Med Dosim. 2011 Spring;36(1):62-70. doi: 10.1016/j.meddos.2009.11.005. Epub 2010 Feb 25.

引用本文的文献

1
CyberKnife Versus Four-Dimensional Computed Tomography-Guided Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer: A Case Report.射波刀与四维计算机断层扫描引导的立体定向体部放射治疗在肺癌治疗中的应用:病例报告
Cureus. 2025 Apr 12;17(4):e82138. doi: 10.7759/cureus.82138. eCollection 2025 Apr.
2
Dosimetric comparison of multiple SBRT delivery platforms for pancreatic cancer.多种胰腺癌 SBRT 治疗平台的剂量学比较。
Eur J Med Res. 2024 Nov 5;29(1):533. doi: 10.1186/s40001-024-02080-3.
3
Accuracy analysis of different dose calculation algorithms for locally advanced pancreatic cancer stereotactic body radiotherapy.

本文引用的文献

1
Borderline resectable pancreatic cancer. Challenges and controversies.交界可切除胰腺癌。挑战与争议。
Cancer Treat Rev. 2018 Jul;68:124-135. doi: 10.1016/j.ctrv.2018.06.006. Epub 2018 Jun 13.
2
Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer.局部晚期胰腺癌调强放疗的临床评价。
Radiat Oncol. 2018 Jun 25;13(1):118. doi: 10.1186/s13014-018-1063-5.
3
Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.
局部晚期胰腺癌立体定向体部放射治疗中不同剂量计算算法的准确性分析
J Cancer. 2023 Sep 4;14(14):2694-2699. doi: 10.7150/jca.87596. eCollection 2023.
对于局部晚期胰腺癌(LAPC),采用调强放疗(IMRT)技术分15至28次递增剂量比三维适形放疗(3DCRT)的标准剂量耐受性更好。
Adv Radiat Oncol. 2017 Mar 18;2(3):403-415. doi: 10.1016/j.adro.2017.02.004. eCollection 2017 Jul-Sep.
4
Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist.胰腺癌的立体定向体部放疗:肿瘤内科医生的批判性综述
J Gastrointest Oncol. 2016 Jun;7(3):479-86. doi: 10.21037/jgo.2015.10.01.
5
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.吉西他滨联合或不联合厄洛替尼治疗 4 个月后局部进展期胰腺癌患者生存的影响:LAP07 随机临床试验。
JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324.
6
Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer.立体定向体部放疗(SBRT)治疗复发性胰腺癌。
J Cancer. 2016 Jan 10;7(3):283-8. doi: 10.7150/jca.13295. eCollection 2016.
7
Characteristics of a novel treatment system for linear accelerator-based stereotactic radiosurgery.基于直线加速器的立体定向放射外科新型治疗系统的特点
J Appl Clin Med Phys. 2015 Jul 8;16(4):125–148. doi: 10.1120/jacmp.v16i4.5313.
8
Current status and progress of pancreatic cancer in China.中国胰腺癌的现状与进展
World J Gastroenterol. 2015 Jul 14;21(26):7988-8003. doi: 10.3748/wjg.v21.i26.7988.
9
Role of Radiotherapy and Newer Techniques in the Treatment of GI Cancers.放疗及新技术在胃肠道肿瘤治疗中的作用。
J Clin Oncol. 2015 Jun 1;33(16):1737-44. doi: 10.1200/JCO.2014.59.9787. Epub 2015 Apr 27.
10
Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848.基于RTOG 0848对接受胰腺癌放疗患者的正常组织受照情况进行评估。
J Gastrointest Oncol. 2015 Apr;6(2):108-14. doi: 10.3978/j.issn.2078-6891.2014.094.